FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293388792> ?p ?o ?g. }

• W4293388792 endingPage "316" @default.
• W4293388792 startingPage "308" @default.
• W4293388792 abstract "Purpose To compare the 5-year outcomes of the Ahmed FP7 Glaucoma Valve (AGV) (New World Medical, Cucamonga, CA) and the Baerveldt 101-350 Glaucoma Implant (BGI) (Abbott Medical Optics, Abbott Park, IL) for the treatment of refractory glaucoma. Design Multicenter, randomized, controlled clinical trial. Participants A total of 276 patients, including 143 in the AGV group and 133 in the BGI group. Methods Patients aged 18 to 85 years with previous intraocular surgery or refractory glaucoma and intraocular pressure (IOP) of ≥18 mmHg in whom glaucoma drainage implant (GDI) surgery was planned were randomized to implantation of an AGV or a BGI. Main Outcome Measures Surgical failure, IOP, visual acuity (VA), use of glaucoma medications, and complications. Results At 5 years, IOP (mean ± standard deviation [SD]) was 14.7±4.4 mmHg in the AGV group and 12.7±4.5 mmHg in the BGI group (P = 0.015). The number of glaucoma medications in use at 5 years (mean ± SD) was 2.2±1.4 in the AGV group and 1.8±1.5 in the BGI group (P = 0.28). The cumulative probability of failure during 5 years of follow-up was 44.7% in the AGV group and 39.4% in the BGI group (P = 0.65). The number of subjects failing because of inadequately controlled IOP or reoperation for glaucoma was 46 in the AGV group (80% of AGV failures) and 25 in the BGI group (53% of BGI failures; P = 0.003). Eleven eyes in the AGV group (20% of AGV failures) experienced persistent hypotony, explantation of implant, or loss of light perception compared with 22 eyes (47% of failures) in the BGI group. Change in logarithm of the minimum angle of resolution VA (mean ± SD) at 5 years was 0.42±0.99 in the AGV group and 0.43±0.84 in the BGI group (P = 0.97). Conclusions Similar rates of surgical success were observed with both implants at 5 years. The BGI produced greater IOP reduction and a lower rate of glaucoma reoperation than the AGV, but the BGI was associated with twice as many failures because of safety issues. To compare the 5-year outcomes of the Ahmed FP7 Glaucoma Valve (AGV) (New World Medical, Cucamonga, CA) and the Baerveldt 101-350 Glaucoma Implant (BGI) (Abbott Medical Optics, Abbott Park, IL) for the treatment of refractory glaucoma. Multicenter, randomized, controlled clinical trial. A total of 276 patients, including 143 in the AGV group and 133 in the BGI group. Patients aged 18 to 85 years with previous intraocular surgery or refractory glaucoma and intraocular pressure (IOP) of ≥18 mmHg in whom glaucoma drainage implant (GDI) surgery was planned were randomized to implantation of an AGV or a BGI. Surgical failure, IOP, visual acuity (VA), use of glaucoma medications, and complications. At 5 years, IOP (mean ± standard deviation [SD]) was 14.7±4.4 mmHg in the AGV group and 12.7±4.5 mmHg in the BGI group (P = 0.015). The number of glaucoma medications in use at 5 years (mean ± SD) was 2.2±1.4 in the AGV group and 1.8±1.5 in the BGI group (P = 0.28). The cumulative probability of failure during 5 years of follow-up was 44.7% in the AGV group and 39.4% in the BGI group (P = 0.65). The number of subjects failing because of inadequately controlled IOP or reoperation for glaucoma was 46 in the AGV group (80% of AGV failures) and 25 in the BGI group (53% of BGI failures; P = 0.003). Eleven eyes in the AGV group (20% of AGV failures) experienced persistent hypotony, explantation of implant, or loss of light perception compared with 22 eyes (47% of failures) in the BGI group. Change in logarithm of the minimum angle of resolution VA (mean ± SD) at 5 years was 0.42±0.99 in the AGV group and 0.43±0.84 in the BGI group (P = 0.97). Similar rates of surgical success were observed with both implants at 5 years. The BGI produced greater IOP reduction and a lower rate of glaucoma reoperation than the AGV, but the BGI was associated with twice as many failures because of safety issues." @default.
• W4293388792 created "2022-08-28" @default.
• W4293388792 creator A5006087398 @default.
• W4293388792 creator A5018089640 @default.
• W4293388792 creator A5018351012 @default.
• W4293388792 creator A5025209148 @default.
• W4293388792 creator A5038475617 @default.
• W4293388792 creator A5051565290 @default.
• W4293388792 creator A5054680679 @default.
• W4293388792 creator A5057271336 @default.
• W4293388792 date "2015-02-01" @default.
• W4293388792 modified "2023-10-06" @default.
• W4293388792 title "Five-Year Treatment Outcomes in the Ahmed Baerveldt Comparison Study" @default.
• W4293388792 cites W1562711580 @default.
• W4293388792 cites W1968108770 @default.
• W4293388792 cites W1971284313 @default.
• W4293388792 cites W1997735838 @default.
• W4293388792 cites W2010543029 @default.
• W4293388792 cites W2047382931 @default.
• W4293388792 cites W2076197016 @default.
• W4293388792 cites W2089776048 @default.
• W4293388792 cites W2099162236 @default.
• W4293388792 cites W2106413124 @default.
• W4293388792 cites W2107715517 @default.
• W4293388792 cites W2108135200 @default.
• W4293388792 cites W2121034226 @default.
• W4293388792 cites W2131132516 @default.
• W4293388792 cites W2160959025 @default.
• W4293388792 cites W3142292247 @default.
• W4293388792 cites W4254756478 @default.
• W4293388792 cites W4296308430 @default.
• W4293388792 cites W63668370 @default.
• W4293388792 cites W98298746 @default.
• W4293388792 doi "https://doi.org/10.1016/j.ophtha.2014.08.043" @default.
• W4293388792 hasPublicationYear "2015" @default.
• W4293388792 type Work @default.
• W4293388792 citedByCount "214" @default.
• W4293388792 countsByYear W42933887922015 @default.
• W4293388792 countsByYear W42933887922016 @default.
• W4293388792 countsByYear W42933887922017 @default.
• W4293388792 countsByYear W42933887922018 @default.
• W4293388792 countsByYear W42933887922019 @default.
• W4293388792 countsByYear W42933887922020 @default.
• W4293388792 countsByYear W42933887922021 @default.
• W4293388792 countsByYear W42933887922022 @default.
• W4293388792 countsByYear W42933887922023 @default.
• W4293388792 crossrefType "journal-article" @default.
• W4293388792 hasAuthorship W4293388792A5006087398 @default.
• W4293388792 hasAuthorship W4293388792A5018089640 @default.
• W4293388792 hasAuthorship W4293388792A5018351012 @default.
• W4293388792 hasAuthorship W4293388792A5025209148 @default.
• W4293388792 hasAuthorship W4293388792A5038475617 @default.
• W4293388792 hasAuthorship W4293388792A5051565290 @default.
• W4293388792 hasAuthorship W4293388792A5054680679 @default.
• W4293388792 hasAuthorship W4293388792A5057271336 @default.
• W4293388792 hasBestOaLocation W42933887922 @default.
• W4293388792 hasConcept C118487528 @default.
• W4293388792 hasConcept C121332964 @default.
• W4293388792 hasConcept C126322002 @default.
• W4293388792 hasConcept C141071460 @default.
• W4293388792 hasConcept C142424586 @default.
• W4293388792 hasConcept C168563851 @default.
• W4293388792 hasConcept C2776766258 @default.
• W4293388792 hasConcept C2778257484 @default.
• W4293388792 hasConcept C2778527774 @default.
• W4293388792 hasConcept C2780819948 @default.
• W4293388792 hasConcept C2781092963 @default.
• W4293388792 hasConcept C2781411149 @default.
• W4293388792 hasConcept C535046627 @default.
• W4293388792 hasConcept C71924100 @default.
• W4293388792 hasConcept C87355193 @default.
• W4293388792 hasConceptScore W4293388792C118487528 @default.
• W4293388792 hasConceptScore W4293388792C121332964 @default.
• W4293388792 hasConceptScore W4293388792C126322002 @default.
• W4293388792 hasConceptScore W4293388792C141071460 @default.
• W4293388792 hasConceptScore W4293388792C142424586 @default.
• W4293388792 hasConceptScore W4293388792C168563851 @default.
• W4293388792 hasConceptScore W4293388792C2776766258 @default.
• W4293388792 hasConceptScore W4293388792C2778257484 @default.
• W4293388792 hasConceptScore W4293388792C2778527774 @default.
• W4293388792 hasConceptScore W4293388792C2780819948 @default.
• W4293388792 hasConceptScore W4293388792C2781092963 @default.
• W4293388792 hasConceptScore W4293388792C2781411149 @default.
• W4293388792 hasConceptScore W4293388792C535046627 @default.
• W4293388792 hasConceptScore W4293388792C71924100 @default.
• W4293388792 hasConceptScore W4293388792C87355193 @default.
• W4293388792 hasIssue "2" @default.
• W4293388792 hasLocation W42933887921 @default.
• W4293388792 hasLocation W42933887922 @default.
• W4293388792 hasLocation W42933887923 @default.
• W4293388792 hasLocation W42933887924 @default.
• W4293388792 hasOpenAccess W4293388792 @default.
• W4293388792 hasPrimaryLocation W42933887921 @default.
• W4293388792 hasRelatedWork W1186832327 @default.
• W4293388792 hasRelatedWork W1898293549 @default.
• W4293388792 hasRelatedWork W1990333822 @default.
• W4293388792 hasRelatedWork W2107715517 @default.
• W4293388792 hasRelatedWork W2141298988 @default.

• next